Research map: Artificial intelligence-assisted proteomic signatures for discriminating malignant from benign pulmonary nodules

Back to the article

Papers in this map

  1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening · The National Lung Screening Trial Research Team · 2011 · 11268 citations · Cited by this paper
  2. Editorial Advisory Board · 2026 · Related
  3. The 2015 World Health Organization Classification of Lung Tumors · William David Travis · 2015 · 4653 citations · Cited by this paper
  4. Single cell RNA-sequencing meta-analysis identifies the molecular signature of smoking cessation on the human lung · 2026 · Related
  5. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial · Harry J. de Koning · 2020 · 3676 citations · Cited by this paper
  6. A self-sustaining repair circuit drives the progression of pulmonary fibrosis · 2026 · Related
  7. Detection and localization of surgically resectable cancers with a multi-analyte blood test · Joshua David Cohen · 2018 · 2878 citations · Cited by this paper
  8. Editorial Advisory Board · 2026 · Related
  9. The global burden of lung cancer: current status and future trends · Amanda C. Leiter · 2023 · 1494 citations · Cited by this paper
  10. Author Guidelines · 2026 · Related
  11. Mining the plasma proteome for cancer biomarkers · Samir Hanash · 2008 · 904 citations · Cited by this paper
  12. From JAK2 degradation to precision immunotherapy: A translational passport for strebloside in Epstein–Barr virus-associated gastric cancer · 2026 · Related
  13. Plasma Proteome Profiling to Assess Human Health and Disease · Philipp Emanuel Geyer · 2016 · 805 citations · Cited by this paper
  14. Editorial Advisory Board · 2026 · Related
  15. Screening for Lung Cancer With Low-Dose Computed Tomography · Daniel E Jonas · 2021 · 657 citations · Cited by this paper
  16. Ion channel dysfunction in acute pancreatitis: mechanisms, heterogeneity, and therapeutic prospects · 2026 · Related
  17. Organ aging signatures in the plasma proteome track health and disease · Hamilton Se‐Hwee Oh · 2023 · 640 citations · Cited by this paper
  18. Autologous airway basal cell transplantation for destroyed lung repair · 2026 · Related
  19. Large-scale plasma proteomics comparisons through genetics and disease associations · Grímur Hjörleifsson Eldjárn · 2023 · 590 citations · Cited by this paper
  20. Circ-PHC3 promotes malignant progression of ovarian cancer through regulating miR-512-3p/SLC2A1/HK2 mediated glucose metabolism · 2026 · Related
  21. Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives · Matthijs Oudkerk · 2020 · 556 citations · Cited by this paper
  22. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring · Wen Li · 2022 · 466 citations · Cited by this paper
  23. Noninvasive proteomic biomarkers for alcohol-related liver disease · Lili Niu · 2022 · 336 citations · Cited by this paper
  24. Utilizing Human Blood Plasma for Proteomic Biomarker Discovery · Jon Jacobs · 2005 · 318 citations · Cited by this paper
  25. Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease · Lili Niu · 2019 · 308 citations · Cited by this paper
  26. Circulating tumor cell isolation for cancer diagnosis and prognosis · Zicheng Deng · 2022 · 302 citations · Cited by this paper
  27. Screening for Lung Cancer · Peter J. Mazzone · 2021 · 264 citations · Cited by this paper
  28. Pan-cancer proteomic map of 949 human cell lines · Emanuel Gonçalves · 2022 · 241 citations · Cited by this paper
  29. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial · Nanda Horeweg · 2013 · 239 citations · Cited by this paper
  30. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis · Guangxi Wang · 2022 · 223 citations · Cited by this paper
  31. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression · Kentaro Inamura · 2018 · 170 citations · Cited by this paper
  32. Plasma proteomic profiles predict individual future health risk · Jia You · 2023 · 157 citations · Cited by this paper
  33. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation · Fei Ren · 2024 · 155 citations · Cited by this paper
  34. Benchmarking commonly used software suites and analysis workflows for DIA proteomics and phosphoproteomics · Ronghui Lou · 2023 · 152 citations · Cited by this paper
  35. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma · Meng Nie · 2021 · 133 citations · Cited by this paper
  36. Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma · Xiaohua Xing · 2023 · 93 citations · Cited by this paper
  37. Evolution of Mass Spectrometry Instruments and Techniques for Blood Proteomics · Yang Chun Zhao · 2023 · 64 citations · Cited by this paper
  38. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer · Qing Hu · 2022 · 62 citations · Cited by this paper
  39. Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage · Haibin Deng · 2022 · 61 citations · Cited by this paper

Source: OpenAlex (CC0)